#VNS
Baseline epiretinal macrophage-like cell density on OCTA predicts anti-VEGF treatment outcomes in branch retinal vein occlusion.
Details: https://www.maxapress.com/article/doi/10.48130/vns-0026-0037
#BRVO #AntiVEGF #OCTA

🚨 JUST IN: $BRVO
Bravo Multinational issues 1.62M preferred shares to MWP, giving MWP ~77% control

#SEC #stocks #investing #BRVO #Mergers
🔗 secwatch.observer